Search

Your search keyword '"CD40 Ligand chemistry"' showing total 86 results

Search Constraints

Start Over You searched for: Descriptor "CD40 Ligand chemistry" Remove constraint Descriptor: "CD40 Ligand chemistry"
86 results on '"CD40 Ligand chemistry"'

Search Results

1. Highly sensitive CD40L protein discrimination via label-free fiber sensing technologies.

2. Crystal structures of human CD40 in complex with monoclonal antibodies dacetuzumab and bleselumab.

Catalog

Books, media, physical & digital resources

3. In silico designing of novel epitope-based peptide vaccines against HIV-1.

4. X-linked hyper-immunoglobulin M syndrome harboring a novel CD40-ligand gene mutation: a case report.

5. Identification and functional characterization of CD154 in T cell-dependent immune response in Nile tilapia (Oreochromis niloticus).

6. Structural Insights into How Protein Environments Tune the Spectroscopic Properties of a Noncanonical Amino Acid Fluorophore.

7. Bacterial Magnetosomes as Novel Platform for the Presentation of Immunostimulatory, Membrane-Bound Ligands in Cellular Biotechnology.

8. Anti-CD40 antibody 2C10 binds to a conformational epitope at the CD40-CD154 interface that is conserved among primate species.

9. A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis.

10. Cytotoxic effect caspase activation dependent of a genetically engineered fusion protein with a CD154 peptide mimetic (OmpC-CD154 p ) on B-NHL cell lines is mediated by the inhibition of bcl-6 and YY1 through MAPK p38 activation.

11. Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy.

12. Identification and characterisation of the CD40-ligand of Sigmodon hispidus.

13. Design, Synthesis, and Evaluation of Novel Immunomodulatory Small Molecules Targeting the CD40⁻CD154 Costimulatory Protein-Protein Interaction.

14. A High Level of Soluble CD40L Is Associated with P. aeruginosa Infection in Patients with Cystic Fibrosis.

15. Cloning and high level expression of the biologically active extracellular domain of Macaca mulatta CD40 in Pichia pastoris.

16. Diagnostic utility of VEGF and soluble CD40L levels in serum of Alzheimer's patients.

17. Generation of a soluble recombinant trimeric form of bovine CD40L and its potential use as a vaccine adjuvant in cows.

18. Characterisation of the TNF superfamily members CD40L and BAFF in the small-spotted catshark (Scyliorhinus canicula).

19. Symmetry Controlled, Genetic Presentation of Bioactive Proteins on the P22 Virus-like Particle Using an External Decoration Protein.

20. Counteractive functions are encrypted in the residues of CD154.

21. The prognostic value of plasma soluble CD40 ligand levels in patients with nasopharyngeal carcinoma.

22. Targeting and liposomal drug delivery to CD40L expressing T cells for treatment of autoimmune diseases.

23. Targeting the HA2 subunit of influenza A virus hemagglutinin via CD40L provides universal protection against diverse subtypes.

24. Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag.

25. Design of vaccine adjuvants incorporating TNF superfamily ligands and TNF superfamily molecular mimics.

26. Quantification of cardiovascular disease biomarkers via functionalized magnetic beads and on-demand detachable quantum dots.

27. Fibronectin type III domains engineered to bind CD40L: cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of two complexes.

28. Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome.

29. Cysteine-rich domain 1 of CD40 mediates receptor self-assembly.

30. The promiscuous protein binding ability of erythrosine B studied by metachromasy (metachromasia).

31. CD40L--a costimulatory molecule involved in the maturation of antigen presenting cells in Atlantic salmon (Salmo salar).

32. Phenotypic heterogeneity in a family with a CD40 ligand intracellular domain mutation.

33. Activation of CD40 with platelet derived CD154 promotes reactive oxygen species dependent death of human hepatocytes during hypoxia and reoxygenation.

34. Lys-des[Arg9]-bradykinin alters migration and production of interleukin-12 in monocyte-derived dendritic cells.

35. A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells.

36. Crystallographic and mutational analysis of the CD40-CD154 complex and its implications for receptor activation.

37. Anti-tumor activity of gene transfer of the membrane-stable CD40L mutant into lung cancer cells.

38. [Effect of sCD40L combined with vinorelbine on lung adenocarcinoma cell A549].

39. [Construction and identification of recombinant adenovirus vector expressing IkappaBalpha-IRES2-shCD40L].

40. CD40 ligand induced cytotoxicity in carcinoma cells is enhanced by inhibition of metalloproteinase cleavage and delivery via a conditionally-replicating adenovirus.

41. Organic dyes as small molecule protein-protein interaction inhibitors for the CD40-CD154 costimulatory interaction.

42. A genetically encoded direct sensor of antibody-antigen interactions.

43. CD154-CD40 interactions are essential for thymus-dependent antibody production in zebrafish: insights into the origin of costimulatory pathway in helper T cell-regulated adaptive immunity in early vertebrates.

44. Molecular characterization of patients with X-linked Hyper-IgM syndrome: description of two novel CD40L mutations.

46. A soluble hexameric form of CD40 ligand activates human dendritic cells and augments memory T cell response.

47. Severe congenital neutropenia or hyper-IgM syndrome? A novel mutation of CD40 ligand in a patient with severe neutropenia.

48. Xenogeneic interaction between human CD40L and porcine CD40 activates porcine endothelial cells through NF-kappaB signaling.

49. Small multivalent architectures mimicking homotrimers of the TNF superfamily member CD40L: delineating the relationship between structure and effector function.

50. Interaction of calreticulin with CD40 ligand, TRAIL and Fas ligand.